Pharma-Bio Serv (OTCMKTS:PBSV) Issues Earnings Results

Pharma-Bio Serv (OTCMKTS:PBSV) announced its quarterly earnings data on Monday. The company reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.03 by ($0.04), Yahoo Finance reports. The company had revenue of $2.42 million for the quarter, compared to analyst estimates of $3.50 million. Pharma-Bio Serv had a negative return on equity of 0.04% and a negative net margin of 0.05%.

Pharma-Bio Serv Stock Performance

OTCMKTS:PBSV opened at $0.63 on Wednesday. Pharma-Bio Serv has a one year low of $0.52 and a one year high of $1.09. The stock has a 50-day simple moving average of $0.62 and a 200 day simple moving average of $0.69.

About Pharma-Bio Serv

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.